Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
In chronic kidney disease, the pivotal FLOW trial demonstrated that semaglutide 1 mg reduced the risk of major kidney events by 24% in patients with type 2 diabetes and CKD, resulting in a dedicated indication in this population
Your starting dose is intentionally lower to allow your body to adapt and reduce side effects
Individual responses to each medication can vary, and before you make the switch, you should consider factors such as your current weight, the effectiveness of your liraglutide treatment plan, and the side effects of semaglutide
Patients who arrive at a new dose already well-hydrated and fiber-sufficient handle the transition significantly better than those who try to adjust after constipation has set in
US$ 26.13
US$ 26.43
US$ 24.44
US$ 20.24
US$ 25.90
US$ 23.36
